The Hepatic Glucose Response to Glucagon at Varying Insulin Levels: Implications for Closed Loop Glycemic Control.
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2013
At a glance
- Drugs Glucagon (Primary) ; Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2012 Planned end date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 22 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.